Your browser doesn't support javascript.
loading
Management and outcomes in critically ill nonagenarian versus octogenarian patients.
Bruno, Raphael Romano; Wernly, Bernhard; Kelm, Malte; Boumendil, Ariane; Morandi, Alessandro; Andersen, Finn H; Artigas, Antonio; Finazzi, Stefano; Cecconi, Maurizio; Christensen, Steffen; Faraldi, Loredana; Lichtenauer, Michael; Muessig, Johanna M; Marsh, Brian; Moreno, Rui; Oeyen, Sandra; Öhman, Christina Agvald; Pinto, Bernardo Bollen; Soliman, Ivo W; Szczeklik, Wojciech; Valentin, Andreas; Watson, Ximena; Leaver, Susannah; Boulanger, Carole; Walther, Sten; Schefold, Joerg C; Joannidis, Michael; Nalapko, Yuriy; Elhadi, Muhammed; Fjølner, Jesper; Zafeiridis, Tilemachos; De Lange, Dylan W; Guidet, Bertrand; Flaatten, Hans; Jung, Christian.
  • Bruno RR; Department of Cardiology, Pulmonary Diseases, and Vascular Medicine, Medical Faculty, Heinrich Heine University of Duesseldorf, Moorenstraße 5, 40225, Duesseldorf, Germany.
  • Wernly B; Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, Austria.
  • Kelm M; Division of Cardiology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Boumendil A; Department of Cardiology, Pulmonary Diseases, and Vascular Medicine, Medical Faculty, Heinrich Heine University of Duesseldorf, Moorenstraße 5, 40225, Duesseldorf, Germany.
  • Morandi A; Cardiovascular Research Institute Düsseldorf (CARID), Duesseldorf, Germany.
  • Andersen FH; Service de Réanimation Médicale, Publique-Hôpital de Paris, Hôpital Saint-Antoine, F-75012, Paris, France.
  • Artigas A; Department of Rehabilitation Hospital Ancelle di Cremona, Cremona, Italy.
  • Finazzi S; Geriatric Research Group, Brescia, Italy.
  • Cecconi M; Department Of Anaesthesia and Intensive Care, Ålesund Hospital, Ålesund, Norway.
  • Christensen S; NTNU, Dep of Circulation and Medical Imaging, Trondheim, Norway.
  • Faraldi L; Department of Intensive Care Medicine, CIBERes Corporacion Sanitaria Universitaria Parc Tauli, Barcelona, Spain.
  • Lichtenauer M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, BG, Italy.
  • Muessig JM; Department of Anaesthesia, IRCCS Instituto Clínico Humanitas, Humanitas University, Milan, Italy.
  • Marsh B; Department of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Moreno R; Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Oeyen S; Department of Cardiology, Paracelsus Medical University, Salzburg, Austria.
  • Öhman CA; Department of Cardiology, Pulmonary Diseases, and Vascular Medicine, Medical Faculty, Heinrich Heine University of Duesseldorf, Moorenstraße 5, 40225, Duesseldorf, Germany.
  • Pinto BB; Mater Misericordiae University Hospital, Dublin, Ireland.
  • Soliman IW; Unidade de Cuidados Intensivos Neurocríticos e Trauma, Faculdade de Ciências Médicas de Lisboa, Hospital de São José, Centro Hospitalar Universitário de Lisboa Central, Nova Médical School, Lisbon, Portugal.
  • Szczeklik W; Department of Intensive Care, 1K12IC Ghent University Hospital, Ghent, Belgium.
  • Valentin A; Karolinska University Hospital, Solna, Sweden.
  • Watson X; Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Leaver S; Department of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, The Netherlands.
  • Boulanger C; Intensive Care and Perioperative Medicine Division, Jagiellonian University Medical College, Kraków, Poland.
  • Walther S; Kardinal Schwarzenberg Hospital, Schwarzach, Austria.
  • Schefold JC; St George's University Hospital, London, UK.
  • Joannidis M; Research Lead Critical Care Directorate St George's Hospital, London, UK.
  • Nalapko Y; NAHP Committee ESICM, Intensive Care Unit, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK.
  • Elhadi M; Linkoping University Hospital, Linkoping, Sweden.
  • Fjølner J; Department of Intensive Care Medicine, Inselspital, Universitätsspital, University of Bern, Bern, Switzerland.
  • Zafeiridis T; Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • De Lange DW; European Wellness International, ICU, Luhansk, Ukraine.
  • Guidet B; Alkhums Hospital, ICU, Tripoli, Libya.
  • Flaatten H; Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
  • Jung C; Intensive Care Unit General Hospital of Larissa, Larissa, Greece.
BMC Geriatr ; 21(1): 576, 2021 10 19.
Article en En | MEDLINE | ID: mdl-34666709
ABSTRACT

BACKGROUND:

Intensive care unit (ICU) patients age 90 years or older represent a growing subgroup and place a huge financial burden on health care resources despite the benefit being unclear. This leads to ethical problems. The present investigation assessed the differences in outcome between nonagenarian and octogenarian ICU patients.

METHODS:

We included 7900 acutely admitted older critically ill patients from two large, multinational studies. The primary outcome was 30-day-mortality, and the secondary outcome was ICU-mortality. Baseline characteristics consisted of frailty assessed by the Clinical Frailty Scale (CFS), ICU-management, and outcomes were compared between octogenarian (80-89.9 years) and nonagenarian (> 90 years) patients. We used multilevel logistic regression to evaluate differences between octogenarians and nonagenarians.

RESULTS:

The nonagenarians were 10% of the entire cohort. They experienced a higher percentage of frailty (58% vs 42%; p < 0.001), but lower SOFA scores at admission (6 + 5 vs. 7 + 6; p < 0.001). ICU-management strategies were different. Octogenarians required higher rates of organ support and nonagenarians received higher rates of life-sustaining treatment limitations (40% vs. 33%; p < 0.001). ICU mortality was comparable (27% vs. 27%; p = 0.973) but a higher 30-day-mortality (45% vs. 40%; p = 0.029) was seen in the nonagenarians. After multivariable adjustment nonagenarians had no significantly increased risk for 30-day-mortality (aOR 1.25 (95% CI 0.90-1.74; p = 0.19)).

CONCLUSION:

After adjustment for confounders, nonagenarians demonstrated no higher 30-day mortality than octogenarian patients. In this study, being age 90 years or more is no particular risk factor for an adverse outcome. This should be considered- together with illness severity and pre-existing functional capacity - to effectively guide triage decisions. TRIAL REGISTRATION NCT03134807 and NCT03370692 .
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad Crítica / Fragilidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad Crítica / Fragilidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 / Humans Idioma: En Año: 2021 Tipo del documento: Article